← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2014Last known activity
Mar 8, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT04792710Lead sponsorPhase 4Mar 8, 2021
- NCT04792710Reponsible party - principal investigatorPhase 4Mar 8, 2021
- NCT04392362Lead sponsorPhase 3Apr 1, 2018
- NCT04392362Reponsible party - principal investigatorPhase 3Apr 1, 2018
- NCT03125551Overall official - principal investigatorN/AJun 1, 2017
- NCT03125551Reponsible party - principal investigatorN/AJun 1, 2017
- NCT03125551Lead sponsorN/AJun 1, 2017
- NCT02750202Overall official - principal investigatorPhase 3Jul 1, 2016
- NCT02750202Lead sponsorPhase 3Jul 1, 2016
- NCT02750202Reponsible party - principal investigatorPhase 3Jul 1, 2016
- NCT02046499Reponsible party - principal investigatorN/AJan 1, 2014
- NCT02046499Overall official - principal investigatorN/AJan 1, 2014
- NCT02046499Lead sponsorN/AJan 1, 2014
Details
- Last known activity
- Mar 8, 2021